AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $481 | – | 1,068 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 1,068 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,068 | -70.7% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 3,646 | +57.0% | 0.00% | – |
| Q2 2022 | $1,000 | -98.3% | 2,322 | -90.7% | 0.00% | – |
| Q1 2022 | $58,000 | -41.4% | 24,923 | +19.4% | 0.00% | – |
| Q4 2021 | $99,000 | -34.9% | 20,878 | +8.8% | 0.00% | – |
| Q3 2021 | $152,000 | -75.1% | 19,187 | -78.1% | 0.00% | – |
| Q2 2021 | $610,000 | +165.2% | 87,633 | +202.2% | 0.00% | – |
| Q1 2021 | $230,000 | -1.3% | 28,996 | -2.0% | 0.00% | – |
| Q4 2020 | $233,000 | +109.9% | 29,598 | +89.1% | 0.00% | – |
| Q3 2020 | $111,000 | -15.3% | 15,654 | +10.8% | 0.00% | – |
| Q2 2020 | $131,000 | -13.8% | 14,123 | -56.8% | 0.00% | – |
| Q1 2020 | $152,000 | -59.0% | 32,689 | -32.5% | 0.00% | – |
| Q4 2019 | $371,000 | -12.1% | 48,458 | -11.6% | 0.00% | – |
| Q3 2019 | $422,000 | +23.0% | 54,841 | +2.6% | 0.00% | – |
| Q2 2019 | $343,000 | +547.2% | 53,450 | +700.9% | 0.00% | – |
| Q1 2019 | $53,000 | +65.6% | 6,674 | +58.6% | 0.00% | – |
| Q4 2018 | $32,000 | -92.7% | 4,207 | -90.8% | 0.00% | – |
| Q3 2018 | $437,000 | -65.6% | 45,712 | -61.9% | 0.00% | – |
| Q2 2018 | $1,270,000 | +153.0% | 120,015 | +136.9% | 0.00% | – |
| Q1 2018 | $502,000 | +1421.2% | 50,652 | +737.2% | 0.00% | – |
| Q4 2017 | $33,000 | +3200.0% | 6,050 | +2925.0% | 0.00% | – |
| Q3 2017 | $1,000 | -80.0% | 200 | -84.4% | 0.00% | – |
| Q2 2017 | $5,000 | – | 1,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $258,000 | 3.49% |
| Aisling Capital Management LP | 1,691,151 | $3,890,000 | 2.10% |
| Sio Capital Management, LLC | 871,101 | $2,004,000 | 0.66% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $6,550,000 | 0.64% |
| Samsara BioCapital, LLC | 883,720 | $2,033,000 | 0.51% |
| Ghost Tree Capital, LLC | 686,599 | $1,579,000 | 0.34% |
| Nantahala Capital Management | 3,200,593 | $7,361,000 | 0.33% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $565,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $9,338,000 | 0.28% |
| Lion Point Capital, LP | 300,000 | $690,000 | 0.16% |